{"Title": "Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes", "Year": 2016, "Source": "Drug Des. Dev. Ther.", "Volume": "10", "Issue": null, "Art.No": null, "PageStart": 4073, "PageEnd": 4078, "CitedBy": 7, "DOI": "10.2147/DDDT.S117080", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85007500697&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Benzoates", "Chelation Therapy", "Deferoxamine", "Drug Therapy, Combination", "Humans", "Iron", "Iron Chelating Agents", "Pyridones", "Syndrome", "Thalassemia", "Triazoles"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85007500697", "SubjectAreas": [["Pharmacology", "PHAR", "3004"], ["Pharmaceutical Science", "PHAR", "3003"], ["Drug Discovery", "PHAR", "3002"]], "AuthorData": {"55598806700": {"Name": "Taher A.T.", "AuthorID": "55598806700", "AffiliationID": "60068761", "AffiliationName": "Department of Internal Medicine, American University of Beirut"}, "7403427269": {"Name": "Porter J.B.", "AuthorID": "7403427269", "AffiliationID": "60022148", "AffiliationName": "Department of Haematology, University College London"}, "6701800299": {"Name": "Kattamis A.", "AuthorID": "6701800299", "AffiliationID": "60028900", "AffiliationName": "First Department of Pediatrics, University of Athens"}, "7003851192": {"Name": "Viprakasit V.", "AuthorID": "7003851192", "AffiliationID": "60011189, 60012718", "AffiliationName": "Department of Pediatrics and Thalassemia Center, Siriraj Hospital, Mahidol University"}, "35433934600": {"Name": "Cappellini M.D.", "AuthorID": "35433934600", "AffiliationID": "60030318, 60007067", "AffiliationName": "Department of Internal Medicine, Universit\u00e0 di Milano, Ca Granda Foundation IRCCS"}}}